Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$13.37 - $18.85 $182,219 - $256,906
-13,629 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$17.59 - $31.05 $44,274 - $78,152
2,517 Added 22.65%
13,629 $251,000
Q4 2018

Feb 13, 2019

SELL
$18.97 - $31.47 $186,816 - $309,916
-9,848 Reduced 46.98%
11,112 $290,000
Q3 2018

Nov 14, 2018

BUY
$18.25 - $23.0 $382,520 - $482,080
20,960 New
20,960 $481,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.